• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

浸润性小叶癌的组织学亚型与肿瘤状态及激素受体的相关性

Histologic subtypes of invasive lobular carcinoma in correlation with tumor status and hormone receptors.

作者信息

Mise Ivana, Vucić Majda, Maricević Ivana, Sokcević Marijka, Curić-Jurić Silva

机构信息

Cytology Division, University Department of Medicine, Sestre milosrdnice University Hospital, Zagreb, Croatia.

出版信息

Acta Clin Croat. 2010 Sep;49(3):275-81.

PMID:21462816
Abstract

Invasive lobular carcinoma is a distinct biological entity with several histologic variants the prognostic value of which is not fully elucidated. The aim of this study was to determine the immunohistochemical expression of estrogen receptors (ER) and progedterone receptors (PR) in subtypes of lobular breast carcinoma (classic and variant types) and to correlate them with clinical and tumor parameters. Fifty lobular carcinomas, i.e. 33 classic and 17 variant, were analyzed. The classic type was more common (66%) and found in older women (61 years of age), smaller in size (1.5 cm), with N0 status and modestly positive ER and PR. The variant types were more frequent in younger women (55 years of age), larger in size (2.5 cm), with N1 status and maximal positive ER and PR. ER was expressed in 82% and PR in 78% of all tumors, mostly with maximal expression. Only one tumor of the classic type was HER/2neu 3+, ER and PR-. ER expression was significantly associated with a decreased incidence of other proliferative lesions (P=0.043). The total sample and the classic type were characterized by a significant positive correlation between ER and PR (P=0.004) and between tumor size and N status (P=0.005), and by negative correlation between HER/2neu and N status (P=0.042). In variant types, larger tumors were related to higher N (P=0.021), while higher ER expression was associated with smaller tumors (P=0.044). The study indicated distinct biological features oflobular carcinoma subtypes and the need for a more selective therapeutic approach.

摘要

浸润性小叶癌是一种独特的生物学实体,有几种组织学变体,其预后价值尚未完全阐明。本研究的目的是确定小叶乳腺癌各亚型(经典型和变异型)中雌激素受体(ER)和孕激素受体(PR)的免疫组化表达,并将它们与临床和肿瘤参数相关联。分析了50例小叶癌,即33例经典型和17例变异型。经典型更常见(66%),见于老年女性(61岁),肿瘤较小(1.5 cm),N0分期,ER和PR呈中等阳性。变异型在年轻女性(55岁)中更常见,肿瘤较大(2.5 cm),N1分期,ER和PR呈强阳性。所有肿瘤中82%表达ER,78%表达PR,大多为强表达。经典型中只有1例肿瘤HER/2neu 3+,ER和PR阴性。ER表达与其他增殖性病变发生率降低显著相关(P=0.043)。总样本和经典型的特征是ER与PR之间(P=0.004)、肿瘤大小与N分期之间(P=0.005)呈显著正相关,HER/2neu与N分期之间呈负相关(P=0.042)。在变异型中,较大肿瘤与较高N分期相关(P=0.021),而较高ER表达与较小肿瘤相关(P=0.044)。该研究表明小叶癌各亚型具有不同的生物学特征,需要更具选择性的治疗方法。

相似文献

1
Histologic subtypes of invasive lobular carcinoma in correlation with tumor status and hormone receptors.浸润性小叶癌的组织学亚型与肿瘤状态及激素受体的相关性
Acta Clin Croat. 2010 Sep;49(3):275-81.
2
Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.女性乳腺癌中her-2/neu基因扩增与其他预后及预测因素的相关性
Breast J. 2005 Jul-Aug;11(4):278-80. doi: 10.1111/j.1075-122x.2005.21463.x.
3
Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method for disease characterization.使用定量氟-18氟脱氧葡萄糖/正电子发射断层扫描成像参数比较三阴性乳腺癌与雌激素受体阳性/孕激素受体阳性/人表皮生长因子受体2阴性乳腺癌:一种对疾病特征描述可能有用的方法。
Cancer. 2008 Mar 1;112(5):995-1000. doi: 10.1002/cncr.23226.
4
Coordinated expression of ER, PR and HER2 define different prognostic subtypes among poorly differentiated breast carcinomas.雌激素受体(ER)、孕激素受体(PR)和人表皮生长因子受体2(HER2)的协同表达在低分化乳腺癌中定义了不同的预后亚型。
Histopathology. 2009 Sep;55(3):346-52. doi: 10.1111/j.1365-2559.2009.03380.x.
5
Do we need HER-2/neu testing for all patients with primary breast carcinoma?对于所有原发性乳腺癌患者,我们都需要进行HER-2/neu检测吗?
Cancer. 2003 Dec 15;98(12):2547-53. doi: 10.1002/cncr.11828.
6
FOXA1 expression in breast cancer--correlation with luminal subtype A and survival.乳腺癌中FOXA1的表达——与腔面A型及生存的相关性
Clin Cancer Res. 2007 Aug 1;13(15 Pt 1):4415-21. doi: 10.1158/1078-0432.CCR-07-0122.
7
Risk factors for hormone receptor-defined breast cancer in postmenopausal women.绝经后女性激素受体定义的乳腺癌的危险因素。
Cancer Epidemiol Biomarkers Prev. 2006 Dec;15(12):2482-8. doi: 10.1158/1055-9965.EPI-06-0489.
8
Morphological profile and association of HER-2/neu with prognostic markers in breast carcinoma in Northern Pakistan.巴基斯坦北部乳腺癌的形态学特征及HER-2/neu与预后标志物的关联
J Coll Physicians Surg Pak. 2009 Feb;19(2):99-103.
9
Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: from the 'MALOVA' ovarian cancer study.雌激素受体和孕激素受体肿瘤表达在丹麦卵巢癌患者中的预后价值:来自“MALOVA”卵巢癌研究
Oncol Rep. 2007 Nov;18(5):1051-9.
10
The expression of cytokeratin 5/6 in invasive lobular carcinoma of the breast: evidence of a basal-like subset?细胞角蛋白5/6在乳腺浸润性小叶癌中的表达:存在基底样亚型的证据?
Hum Pathol. 2008 Mar;39(3):331-6. doi: 10.1016/j.humpath.2007.07.014.

引用本文的文献

1
A CASE OF INFILTRATING LOBULAR CARCINOMA OF THE BREAST WITH GASTRIC METASTASIS 22 YEARS AFTER INITIAL SURGERY.浸润性小叶乳腺癌术后 22 年胃转移 1 例
Acta Clin Croat. 2021 Mar;60(1):136-140. doi: 10.20471/acc.2021.60.01.20.
2
Comparison of Syndecan-1 Immunohistochemical Expression in Lobular and Ductal Breast Carcinoma with Nodal Metastases.比较有淋巴结转移的乳腺导管癌和乳腺小叶癌中硫酸乙酰肝素蛋白聚糖-1 的免疫组化表达。
Anal Cell Pathol (Amst). 2018 Jul 29;2018:9432375. doi: 10.1155/2018/9432375. eCollection 2018.
3
Breast Cancer in Turkey: Clinical and Histopathological Characteristics (Analysis of 13.240 Patients).
土耳其的乳腺癌:临床和组织病理学特征(对13240例患者的分析)
J Breast Health. 2014 Apr 1;10(2):98-105. doi: 10.5152/tjbh.2014.1988. eCollection 2014 Apr.